Browsing School of Public Health by Author "Laing, Richard O."
Now showing items 1-5 of 5
-
Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya
Wirtz, Veronika J.; Turpin, Kristen; Laing, Richard O.; Mukiira, Carol K.; Rockers, Peter C. (Wiley, 2018)OBJECTIVES: To assess access to noncommunicable diseases (NCD) medicines in Kenya for patients diagnosed and prescribed treatment for asthma, diabetes and hypertension. METHODS: Households in eight purposively chosen ... -
Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: A cross-sectional survey in eight counties
Laing, Richard O.; Ashigbie, Paul G.; Rockers, Peter C. (BMJ Publishing Group, 2020)The objective of this study was to determine the availability and prices of medicines for non-communicable diseases (NCDs) in health facilities and private for-profit drug outlets in Kenya. Design Cross-sectional study. ... -
Coping with access barriers to non‐ communicable disease medicines: Qualitative patient interviews in eight counties in Kenya
Ng, Gloria; Raskin, Elizabeth; Laing, Richard O. (BMC, 2021)There is rich literature on barriers to medicines access for the treatment of non-communicable diseases (NCDs) in high-income countries. Less is known about low- and middle-income countries, in particular the differences ... -
Public reporting on pharmaceutical industry-led access programs: Alignment with the WHO medicine programs evaluation checklist
Laing, Richard O.; Umeh, Chukwuemeka Anthony; Rockers, Peter C. (Springer Nature, 2020)There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organization (WHO) ... -
Willingness to pay brand premiums for generic medicines in Kenya: A bidding game experiment
Laing, Richard O.; Rockers, Peter C.; Kiragu, Zana Wangari; Onyango, Monica A.; Wirtz, Veronika J. (John Wiley and Sons Ltd, 2023)Background: Recent growth in the market share of higher priced branded generic medicines in low- and middle-income countries (LMICs) has raised concerns around affordability and access. We examined consumer willingness to ...